MDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2
touchMDT for touchONCOLOGY
Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Pathologist – Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs outside of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.